Anthony Klon

Anthony Klon is a Senior Scientific Director at Lockwood since February 2022. Before that, they worked as a Scientific Director at Lockwood starting in April 2021 until February 2022. Prior to their role at Lockwood, Anthony was an Assistant Medical Director at Ogilvy CommonHealth Worldwide from April 2017 to April 2021. Anthony also served as a Senior Medical Writer at Axiom by ApotheCom | A Huntsworth Health Company from October 2015 to April 2017. Additionally, Anthony worked as a Medical Director at Guidemark Health (formerly Tricore, Inc.) from March 2015 to October 2015, and previously as a Medical Director at Tricore Inc. from August 2013 until October 2015. Anthony also held roles as a Senior Medical Writer and Contract Medical Writer at Tricore Interactive from December 2011 to August 2013. Prior to that, Anthony was a Senior Scientist and Team Leader at Locus Pharmaceuticals from September 2009 to May 2011, and a Scientist at Locus Pharmaceuticals from September 2008 to September 2009. Anthony also worked as a Senior Scientist at Pharmacopeia from April 2008 to August 2008, and as a Research Scientist at Pharmacopeia Drug Discovery from March 2005 to March 2008. Anthony started their career as a Postdoctoral Fellow at Novartis from June 2002 to March 2005.

Anthony Klon, a biochemistry expert, obtained their Bachelor of Science degree in Biochemistry from the University of Washington. Anthony completed their undergraduate education from 1993 to 1997. Later, they pursued a PhD in Biochemistry at the University of Alabama at Birmingham. Anthony successfully completed their doctoral studies between 1997 and 2002.